rs28763904

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000158.4(GBE1):​c.176T>C​(p.Ile59Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00827 in 1,571,730 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0058 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 64 hom. )

Consequence

GBE1
NM_000158.4 missense

Scores

2
8
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 7.79
Variant links:
Genes affected
GBE1 (HGNC:4180): (1,4-alpha-glucan branching enzyme 1) The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008882791).
BP6
Variant 3-81705581-A-G is Benign according to our data. Variant chr3-81705581-A-G is described in ClinVar as [Benign]. Clinvar id is 255386.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-81705581-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00585 (890/152224) while in subpopulation NFE AF= 0.00876 (596/68014). AF 95% confidence interval is 0.00818. There are 2 homozygotes in gnomad4. There are 424 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GBE1NM_000158.4 linkc.176T>C p.Ile59Thr missense_variant Exon 2 of 16 ENST00000429644.7 NP_000149.4 Q04446Q59ET0
GBE1XR_007095662.1 linkn.304T>C non_coding_transcript_exon_variant Exon 2 of 15

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GBE1ENST00000429644.7 linkc.176T>C p.Ile59Thr missense_variant Exon 2 of 16 1 NM_000158.4 ENSP00000410833.2 Q04446
GBE1ENST00000489715.1 linkc.53T>C p.Ile18Thr missense_variant Exon 2 of 16 2 ENSP00000419638.1 E9PGM4

Frequencies

GnomAD3 genomes
AF:
0.00585
AC:
890
AN:
152106
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00847
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00876
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00751
AC:
1426
AN:
189944
Hom.:
10
AF XY:
0.00710
AC XY:
721
AN XY:
101526
show subpopulations
Gnomad AFR exome
AF:
0.00201
Gnomad AMR exome
AF:
0.0189
Gnomad ASJ exome
AF:
0.00189
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00121
Gnomad FIN exome
AF:
0.00386
Gnomad NFE exome
AF:
0.00919
Gnomad OTH exome
AF:
0.00640
GnomAD4 exome
AF:
0.00853
AC:
12105
AN:
1419506
Hom.:
64
Cov.:
30
AF XY:
0.00822
AC XY:
5773
AN XY:
702562
show subpopulations
Gnomad4 AFR exome
AF:
0.00142
Gnomad4 AMR exome
AF:
0.0160
Gnomad4 ASJ exome
AF:
0.00169
Gnomad4 EAS exome
AF:
0.0000264
Gnomad4 SAS exome
AF:
0.00144
Gnomad4 FIN exome
AF:
0.00456
Gnomad4 NFE exome
AF:
0.00970
Gnomad4 OTH exome
AF:
0.00801
GnomAD4 genome
AF:
0.00585
AC:
890
AN:
152224
Hom.:
2
Cov.:
32
AF XY:
0.00570
AC XY:
424
AN XY:
74420
show subpopulations
Gnomad4 AFR
AF:
0.00265
Gnomad4 AMR
AF:
0.00846
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00377
Gnomad4 NFE
AF:
0.00876
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00786
Hom.:
10
Bravo
AF:
0.00605
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00301
AC:
11
ESP6500EA
AF:
0.00797
AC:
65
ExAC
AF:
0.00532
AC:
637
Asia WGS
AF:
0.00144
AC:
5
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

GBE1: BS1, BS2 -

Mar 20, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 07, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Oct 30, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Glycogen storage disease, type IV Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Dec 04, 2019
Natera, Inc.
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Adult polyglucosan body disease Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Glycogen storage disease, type IV;C1856301:Glycogen storage disease IV, classic hepatic Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
D;T
Eigen
Uncertain
0.64
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.80
T;T
MetaRNN
Benign
0.0089
T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Uncertain
2.8
M;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-4.1
D;D
REVEL
Uncertain
0.44
Sift
Benign
0.034
D;D
Sift4G
Uncertain
0.029
D;D
Polyphen
0.77
P;P
Vest4
0.75
MVP
0.55
MPC
0.078
ClinPred
0.034
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.56
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28763904; hg19: chr3-81754732; COSMIC: COSV101450120; API